Membership
The Working Group is a pathology-driven group of experts, assisted by experts clinicians, scientist and statisticians. The Working Group is open to open to include all pathologists willing to get involved in the activities of the group.
Please send an email to roberto@salgado.be
Information on Membership
-
- Membership of the Working Group is on a voluntary basis.
- All members will receive 2-3 times a year a mailing from the chair of the WG with the details of the ongoing projects so that all remain informed.
- This communication is done by e-mail and a copy of this mailing is posted on the BLOG of the TIL-website, under the item “Practical Info for all members”.
- In order to achieve uniformity in the methodology of scoring TILs worldwide, each member is encouraged to use the Internationally accepted guideline and do their part for promotion and dissemination of the guideline.
The following is a list of current members of the International Immuno-Oncology Working Group (TILs Working Group)*. A member is defined as a person willing to be involved, informed and be part of the activities of the TILs Working Group. The authors alone are responsible for the views expressed in the work of the TILs Working Group and they do not necessarily represent the decisions, policy or views of their employer.
- Roberto Salgado, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium (Co-Chair, Founder, Core-Group Member)
- Sherene Loi, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia (Co-Chair, Founder, Core-Group Member)
- Carsten Denkert, University of Marburg, Marburg, Germany (Co-Chair, Founder, Core-Group Member)
- Sunil Badve, Department of Pathology, Indiana University, Indianapolis, USA (Founder, Core-Group Member)
- Sandra Demaria, Department of Pathology, Weill-Cornell Medicine, New York, USA (Founder, Core-Group Member)
- Sylvia Adams, Perlmutter Cancer Center, New York University Medical School, New York, USA (Founder, Core-Group Member)
- Stefan Michiels, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France (Founder, Core-Group Member)
- David Rimm, Department of Pathology, Yale University School of Medicine, New Haven, USA (Core-Group Member)
- Fraser Symmans, Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, USA (Core-Group Member)
- Stephen Hewitt, Experimental Pathology Laboratory, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, USA (Core-Group Member)
- John Bartlett, Ontario Institute for Cancer Research, Toronto, Canada; IGGM Edinburgh, UK (Core-Group Member)
- Torsten Nielsen, Genetic Pathology Evaluation Centre, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada (Core-Group Member)
- Christos Sotiriou, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium (Core-Group Member)
- Giuseppe Viale, Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy (Core-Group Member)
- Giancarlo Pruneri, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico–Isituto Nazionale dei Tumori, Universita degli Studi di Milano, Milan, Italy (Core-Group Member)
- Sybille Loibl, dlw Laborsoftware UG (haftungsbeschränkt) Lübben, Germany (Core-Group Member)
- Abaete Canto, Surgical Pathology, SBP
- Aicha Ben Taieb, Roche
- Aini Hyytiäinen, Department of Oral and Maxillofacial Diseases, Helsinki, Finland
- Akira I. Hida, Department of Pathology, Matsuyama Shimin Hospital, Ehime, Japan
- Akli Hanane – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Alastair Thompson, Surgical Oncology, Baylor College of Medicine, Texas, USA
- Albrecht Stenzinger, Institute of Pathology Heidelberg (IPH), University Hospital Heidelberg, Heidelberg, Germany
- Alejandra Wernicke, Anatomical Pathology, Hospital Italiano de Buenos Aires, Argentina
- Alejandro Rojo-Sebastian – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Aleksei Konstantinov, Department of Pathology, Saint-Petersburg clinical scientific and practical center for specialised types of medical care (oncological), St.Petersburg, Russia.
- Ales Ales, The Fingerland Department of Pathology, University Hospital Hradec Kralove, Czech Republic
- Alex Lefevre, Roche Diagnostics, Belgium
- Alex Decaluwe, Department of Radiology, Jules Bordet Institute, Belgium
- Alexander Emelyanov – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Alexander Makanga, Histopathology Department, Betsi Cadwaladr University Health Board, United Kingdom
- Alexander J. Lazar, Departments of Pathology, Genomic Medicine, Dermatology, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Alfredo Butera – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Alicia Iturriagagoitia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Allen Gown, PhenoPath Laboratories, Seattle, USA
- Amalika Edirisinghe, Pathology, NSW Health, Gosford, Australia
- Amanda Lowe, Visiopharm
- Amine Kallala, Hopitalle Charles Nicolle, Tunisia
- Amy Lo, Research Pathology, Genentech Inc., South San Francisco, USA
- An Coosemans, Oncology, Laboratory of Tumor Immunology and Immunotherapy, KU Leuven, Belgium
- Ana Calatrava, Fundacion Intituto Valenciano de Oncologia, Valencia, Spain
- Ana Godoy – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Ana Ramirez – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Ana C. Garrido Castro, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Anant Madabhushi, Case Western Reserve University; Louis Stokes Cleveland Veterans Health Administration Medical Center, Ohio, USA
- Anders Dahlstrand – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Andre Moreira, Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University, New York, New York, USA
- Andrea Richardson, Department of Pathology, Johns Hopkins Hospital, Baltimore, USA
- Andrea Vingiani, Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan, Italy
- Andreas Koulovasilopoulos – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org United Kingdom
- Andrew Tutt, Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom
- Andrew H. Beck, PathAI, Inc., Cambridge, USA
- Andrew M. Bellizzi, Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, USA
- Angel Guerrero, Department of Oncology, IVO Valencia, Spain
- Angela Quintana, Vall d’Hebrón Hospital Research Institute, Autoimmune Diseases department, Barcelona, Spain
- Angela Thiel – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Aniko Kovacs – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Anita Cassiano – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Anita Grigoriadis , Cancer Bioinformatics Lab, Cancer Centre at Guy’s Hospital, London, UK; School of Life Sciences and Medicine, King’s College London, London, United Kingdom
- Anna Ehinger, Department of Clinical Genetics and Pathology, Skåne University Hospital, Lund University, Lund, Sweden
- Anna Sapino, University of Turin / Candiolo Cancer Institute – FPO, IRCCS, Candiolo, Italy
- Anne Martel, Medical Biophysics, University of Toronto, Toronto, Canada
- Anne Vincent-Salomon, Institut Curie, Department of Pathology, Inserm U934,Paris Sciences Lettres University, Paris, France
- Anne-Vibeke Laenkholm, Department of Surgical Pathology Zealand University Hospital, Demark
- Anthony Gill, University of Sydney, Sydney, Australia
- Antonio Wolff, Breast Cancer Trials, Women’s Malignancies Disease Group, The Johns Hopkins Kimmel Cancer Center, Baltimore, MD, USA
- Aparna Harbhajanka, Department of Pathology, University Hospitals Cleveland Medical Center affiliated with Case Western University, Ohio, USA
- Arif Jahangir, Cancer Biology and Therapeutics Laboratory, School of Biomolecular and Biomedical Science, UCD Conway Institute, Dublin, Ireland
- Arman Rahman, Precision Oncology Ireland, Conway Institute, UCD Ireland
- Arthur Schreurs, Public Health and Primary Care, Katholieke Universiteit Leuven, Belgium
- Ashish Sharma, Department of Biomedical Informatics, Emory University, GA, USA
- Ashley Cimino-Mathews, Departments of Pathology and Oncology, The Johns Hopkins Hospital, Baltimore, USA
- Ashok Srinivasan , National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania, USA
- Asokan Paupathy, Department of Pathology, NSW Health Pathology, NSW Australia
- Ayushi Sahay, Pathology, Tata Memorial Centre, Mumbai, India
- Bai Baibai – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Balazs Acs, Department of Pathology, Karolinska Institute, Sweden
- Baljit Singh, Department of Pathology, New York University Langone Medical Centre, New York, USA
- Beatriz Lopez – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Belma Dogdas – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Benjamin Calhoun, Department of Pathology and Laboratory Medicine, UNC School of Medicine, USA
- Benjamin Haibe-Kans, Bioinformatics and Computational Genomics Laboratory, Princess Margaret Cancer Center, Toronto, Canada
- Benjamin Solomon, Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
- Bernadette McLaren – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Bernardo L Rapoport, The Medical Oncology Centre of Rosebank, Johannesburg, South Africa
- Bibhusal Thapa, Department of Medicine, University of Melbourne, Parkville, Australia
- Xiaoxian (Bill) Li, Emory University, USA
- Brad H. Nelson, Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency, Victoria, Canada
- Brandon Gallas, Division of Imaging, Diagnostics, and Software Reliability, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, USA
- Carla Valenti – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Carlos Dos Anjo, Merck
- Carlos Castaneda, Department of Research, Instituto Nacional de Enfermedades Neoplásicas, Lima, Perú
- Carlos Hagen, Palex Medical SA – Exact Sciences Corp, Spain
- Carmen Ballesteros-Merino, Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute/Providence Cancer Center, Portland, Oregon, USA
- Carmen Criscitiello, Department of Medical Oncology, Istituto Europeo di Oncologia, Milan, Italy
- Carolien Boeckx, Roche Diagnostics, Belgium
- Carolien van Deurzen, Department of Pathology, Erasmus MC, Cancer Institute, Rotterdam, The Netherlands
- Caroline Carey, Roche Diagnostics, Belgium
- Caterina Marchio, University of Turin at Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
- Cecile Colpaert, Department of Pathology, AZ Turnhout, Turnhout, Belgium
- Cecily Quinn, Department of Pathology, St Vincent’s University Hospital and University College Dublin, Dublin, Ireland
- Chakra S. Chennubhotla, Department of Computational and Systems Biology, University of Pittsburgh, USA
- Chanel Smart – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Charles Parker, UCL Cancer Institute, United Kingdom
- Charles Swanton, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, United Kingdom
- Chau Huynh Giang, Pathology, Hung Vuong Hospital, Vietnam
- Cian Martyn – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Cinzia Solinas, Azienda AUSL, Regional Hospital of Aosta, Aosta, Italy
- Clare Yu, Department of Physics and Astronomy, University of California, Irvine, Irvine, CA, USA
- Crispin Hiley, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, United Kingdom
- Cynthia Chauhan, Mayo Clinic Breast SPORE, Mayo Clinic, Rochester, MN, USA
- Damien Drubay, Gustave Roussy, Universite Paris-Saclay, Villejuif, France; Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France
- Damilys Joelly Santos – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Daniel Bethmann, University Hospital Halle (Saale), Institute of Pathology, Halle (Saale), Germany
- Daniel Stover, Ohio State University Comprehensive Cancer Center, Ohio, USA
- Daniel Sur, Department of Medical Oncology, University of Medicine “I. Hatieganu” Cluj Napoca, Romania
- Danny Jang – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- David Clunie, Consulting, PixelMed, Pennsylvenia, USA
- David Williams, Anatomical Pathology, Austin Health, Heidelberg, Australia
- David A. Moore, Department of Pathology, UCL Cancer Institute, UCL, London, UK; University College Hospitals NHS Trust, London, United Kingdom
- Deborah A. Dillon, Department of Pathology, Brigham and Women’s Hospital, Boston, MA Department of Pathology, Dana Farber Cancer Institute, Boston, MA, USA
- Denis Larsimont, Department of Pathology, Jules Bordet Institute, Brussels, Belgium
- Dhanusha Sabanathan, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia
- Dhanvi Mathur, Life Sciences, Ahmedabad University, Gujarat, India
- Diana Ruiz – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Dieter Peeters, HistoGeneX NV, Antwerp, Belgium and AZ Sint-Maarten Hospital, Mechelen, Belgium
- Dimitrios Zardavas, Oncology Clinical Development, Bristol-Myers Squibb, Princeton, USA
- Dongyan Liu – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Dora Sabino – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Doris Hoeflmayer, Institut für Pathologie , UK Hamburg, Germany
- Douglas B. Johnson, Department of Medicine, Vanderbilt University Medical Centre, Nashville, USA
- Duilio Della Libera – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Aubrey Thompson, Department of Cancer Biology, Mayo Clinic, Jacksonville, USA
- Edgardo Parrilla Castellar, Q2 Solutions, USA
- Edi Brogi, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Edith Perez, Department of Oncology, Mayo Clinic, Rochester, USA
- Eduardo Rrichardet, Instituto Oncológico Córdoba, Spain
- Ehab ElGabry, Roche, Tucson, USA
- Eiichi Konishi, Departments of Surgical Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Eiji Suzuki, Kyoto University, Department of Breast Surgery, Kyoto, Japan.
- El Attar Hicham Biohisto Group, Annasr Pathology Center, Jedida, Morroco Morocco
- Eldad Klaiman, Roche
- Elena Provenzano, Department of histopathology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Cambridge, United Kingdom
- Elisabeth Ida Specht Stovgaard, Department of Pathology, Herlev and Gentofte University Hospital, Herlev, Denmark
- Elizabeth F. Blackley, Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
- Elżbieta Senkus-Konefka, Department of Oncology & Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland
- Elton Rexhepaj, Research & Development, Sanofi
- Elvire Roblin, Université Paris-Saclay, Univ. Paris-Sud, Villejuif, France; and Service de biostatistique et d’épidémiologie, Gustave Roussy, Villejuif, France
- Emad Shash, Breast Cancer Comprehensive Center, National Cancer Institute, Cairo University, Cairo, Egypt
- Emarene Kalaw – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Emiel Janssen, Department of Pathology, Stavanger University Hospital, Norway; Griffith University, Australia
- Emilio Bria, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
- Emily Reisenbichler, Department of Pathology, Yale School of Medicine, New Haven, USA
- Emma Colliver – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Enrico Orvieto, UOC Anatomia Patologica, ULSS5 Polesana Rovigo, Italy
- Enrique Bellolio, Department of Anatomic Pathology, Faculty of Medicine, Universidad De La Frontera, Temuco Chile
- Erich Huang, National Cancer Institute, Maryland, USA
- Eslie Dennis, Ventana
- Eudald Felip, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.
- Eunice Spengler, Departmento de Patologia, Hospital Universitario Austral, Argentina.
- Eva Balslev, Department of Pathology, Herlev and Gentofte Hospital, Denmark
- Ewa Chmielik, Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland
- Ewan Millar, NSW Health Pathology, St George Hospital, Sydney, Australia
- Fabien Gaire, Pathology and Tissue Analytics, Roche
- Fabrice Andre, Department of Medical Oncology, Gustave Roussy, Villejuif, France
- Fang Fan, Department of Pathology, University of Kansas Medical Center, USA
- Fang-I Lu, Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, Canada
- Farid Azmoudeh-Ardalan, Tehran University of Medical Sciences, Iran
- Fatima Cardoso, Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal
- FayÇõal Abbad – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Federica Miglietta, Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy
- Federico Rojo, Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain
- Felicia Leion – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Felip Garcia, Pathology Department, Hospital Quiron Salud Spain
- Fernando Schmitt, Department of Pathology, Medical Faculty of Porto University, Porto, Portugal.
- Filipp Ofra – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Filomena Carvalho – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Fiorela Mego Ramirez – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Fiorita Mundim – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Francesco Ciompi, Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
- Franciszek Binczyk – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Franklin Peale, Oncology Biomarker Development, Genentech-Roche
- Franklin Sedarat, Q2 Solutions, USA
- Franz Burger – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Fred R. Hirsch, Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, USA
- Frederick Klaushen, Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany
- Frederique Penault-Llorca, Centre de Lutte Contre le cancer – Centre Jean Perrin, Clermont-Ferrand, France
- Gabor Cserni, Department of Pathology, Bács-Kiskun County Teaching Hospital, Kecskemét, Hungary; Department of Pathology, University of Szeged, Szeged, Hungary.
- Gabriela Acosta-Haab, Department of Pathology, Hospital de Oncología Maria Curie, Buenos Aires, Argentina
- Gabriela IzabelaBaltatescu – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Galina Khramtsova – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Gavin Harris, Canterbury Health Laboratories, New Zealand
- Gazzi Carla – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- GǬlcihan Eker – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Gediminas Smailys – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Gelareh Farshid, Directorate of Surgical Pathology, SA Pathology, Adelaide, Australia
- George Kumar, Bristol Myers Squibb, USA
- Gert Van den Eynden, Department of Pathology, GZA-ZNA Ziekenhuizen, Wilrijk, Belgium
- Giampaolo Bianchini, Medical Oncology, San Raffael Scientific Institute, Italy
- Giampaolo Tortora – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Giovanna Garufi, Medical Oncology Unit, Agistino Gemelli IRCCS Polyclinic Foundation, Rome, Italy.
- Giuseppe Floris, KU Leuven- Univerisity of Leuven, Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research and KU Leuven- University Hospitals Leuven, Department of Pathology, Leuven, Belgium Belgium
- Giuseppe Curigliano, University of Milano, Istituto Europeo di Oncologia, IRCCS, Milano, Italy
- Gizem Oner, Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital Belgium
- Glenn Broeckx, Department of Pathology, University Hospital Antwerp, Belgium
- Gloria Inurrigarro – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Gun Min Kim – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Guray Akturk, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Gwen Dackus – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org Netherlands
- Hannah Wen, Memorial Sloan Kettering Cancer Centre, USA
- Harmut Koeppen, Research Pathology, Genentech Inc., South San Francisco, USA
- Harry Haynes, Translational Health Sciences, Department of Cellular Pathology, North Bristol NHS Trust, University of Bristol, United Kingdom
- Heather McArthur, Medical Oncology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, USA
- Heikki Joensuu, Helsinki University Central Hospital, Helsinki, Finland
- Helena Olofsson, Department of Clinical Pathology, Akademiska University Hospital, Uppsala, Sweden
- Hernan Garcia Rivello, Anatomical Pathology, Hospital Italiano de Buenos Aires, Argentina.
- Hirofumi Matsumoto, Department of Pathology, Nakagami Hospital, Okinawa, Japan
- Houssein Sater – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Huang-Chun Lien, Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan
- Hugo M. Horlings, Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Hyun Joo Choi, St. Vincent’s Hospital, The Catholic University of Korea, Seoul, South Korea
- Ian Cree, International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France
- I-Chun Chen, Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, College of Medicine, National Taiwan University, Taipei, Taiwan
- Ida Pavon, Ulss 3, Italy
- Ignasi Roig I Quilis, Departmento de Anatomia Patologica, Hospital de Terrassa, Barcelona, Spain
- Ilaria Porcellato, Department of Veterinary Medicine, University of Perugia, Italy
- Indu Arun, Department of Histopathology, Tata Medical Center, Kolkata, Indi
- Inna Ganshina – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Inne Nauwelaers, Public Health and Primary Care, KU Leuven, Belgium
- Inta Liepniece- Karele – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Ioannis Roxanis, Institute of Cancer Research, United Kingdom
- Ipek Coban, Anatomic Pathology, Istanbul Florence Nightingale Hospital, Turkey
- Iris Nederlof, Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Isaac Garcia-Murillas, Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom
- Isabel Amendoeira, Serviço de Anatomia Patológica, Centro Hospitalar Universitario de São João and Ipatimup, Porto, Portugal
- Isabel Frahm, Department of Pathology, Sanatorio Mater Dei, Buenos Aires, Argentina
- Isabella Castellano, Department of Medical Sciences, University of Turin, Italy
- Iva Brcic, Institute of Pathology, Medical University of Graz, Austria
- Jacinta Fong, Harry Perkins Institute of Medical Research, University of Western Australia
- Jack Chan, Department of Oncology, National Cancer Centre, Singapore
- Jacqueline A. Hall, Vivactiv Ltd, Bellingdon, Bucks, United Kingdom
- James Ziai, Research Pathology, Genentech Inc., South San Francisco, USA
- Jan Hudeek, Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Jane Brock, Department of Pathology, Brigham and Women’s Hospital, Boston, USA
- Janina Kulka, Department of Pathology, Semmelweis University, Budapest, Hungary
- Javier Cortes, Head breast Cancer Program, Oncology Department, IOB institute of Oncology, Quiron Group, Spain
- Jean-Christophe Tille, Department of Pathology, University Hospital, Geneva, Switzerland
- Jeffrey Fine – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Jeffrey Shear, Information Technology, Wiss & Company, LLP, J Shear Consulting, LLC, New York, USA
- Jelle Wesseling, Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
- Jennifer Giltnane, Research Pathology, Genentech Inc., South San Francisco, USA
- Jennifer Kerner, PathAI Inc., Cambridge, USA
- Jeppe Thagaard, DTU Compute, Department of Applied Mathematics, Technical University of Denmark; Visiopharm A/S, Denmark
- Jeremy Braybrooke, Nuffield Department of Population Health, University of Oxford, Oxford and Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
- Jeremy Thomas, Q2 Solutions, USA
- Jeroen Van der Laak, Computational Pathology Group, Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands
- Jerome Lemonnier, R&D UNICANCER, Paris, France
- Jiping Zha, Translational Sciences, MedImmune, Gaithersberg, USA
- Joana Ribeiro, Breast Unit, Champalimaud Clinical Centre, Lisboa, Portugal
- Jochen K. Lennerz, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA
- Jodi M. Carter, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
- Joel Saltz, Department of Biomedical Informatics and Department of Pathology, Stony Brook School of Medicine, Stony Brook, USA
- Joël Cucherousset, GHI Le Raincy-Montfermeil, Chelles, Île-de-France, France
- Johan Hartman, Deptartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
- Johan Lundin, Institute for Molecular Medicine Finland, University of Helsinki, Finland
- John Cochran, Q2 Solutions, Atlanta, GA, USA
- John Le Quesne, Leicester Cancer Research Centre, University of Leicester, Leicester, and MRC Toxicology Unit, University of Cambridge, United Kingdom
- Jonathan Klein, Albert Einstein College of Medicine in New York, USA
- Jonathon W. Juco, Merck & Co., Inc., Kenilworth, USA
- Jorge Reis-Filho, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA and Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Jorge Adriano Ferreira Pinheiro – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Jose van den Berg, Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Jose Fernando do prado Moura, Centro de Pesquisas Clinicas do IMIP, Brasil
- Jose Ignacio Chacan – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Jose Luis Solorzano Rendon, Pathology and Molecular Diagnostics department, MD Anderson Cancer Center Madrid, Spain
- Josefine Sandstrom, Linköping University, Sweden
- Joselyn Sanchez, Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
- Joseph Anderson – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Joseph Sparano, Department of Medicine, Department of Obstetrics & Gynecology and Women’s Health, Albert Einstein Medical Center, Bronx, USA
- Juan Carlos Araya, Department of Pathology, Universidad de La Frontera, Temuco, Chile
- Julian Iturbe – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Juliana Freitas, Pathology Department, Federal University of Bahia, Brazil
- Julien Adam, Department of Pathology, Gustave Roussy, Grand Paris, France
- Junjeong Choi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Junzo Kawaguchi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Justin M. Balko, Departments of Medicine and Cancer Biology, Vanderbilt University Medical Centre, Nashville, USA
- Kai Saeger, Vm Scope, Germany
- Kareem Hosny, Department of Pathology, University of Pennsylvania, USA
- Karen Willard-Gallo, Molecular Immunology Unit, Institut Jules Bordet, Brussels, Belgium
- Karsten Weber, German Breast Group, Neu-Isenburg, Germany
- Karthickbalan Subramanian – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Katey Enfield – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Katherine Elfer, Division of Imaging, Diagnostics, and Software Reliability, US Food and Drug Administration, Silver Spring, MD, USA
- Katherine Pogue-Geile, NSABP/NRG Oncology, Pittsburgh, PA, USA
- KatsuhiroYoshikawa, Kansai Medical University Medical Center, Osaka, Japan
- Keith E. Steele, Translational Sciences, MedImmune, Gaithersberg, USA
- Kenneth Emancipator, Merck & Co., Inc., Kenilworth, USA
- Kevin Thia – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Khalid El Bairi, Cancer Biomarkers Working Group, Oujda, Morocco
- Khalid Abdul Jabbar, Centre for Evolution and Cancer; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
- Kim R.M. Blenman, Department of Internal Medicine, Section of Medical Oncology, Yale Cancer Center, Yale University, School of Medicine, New Haven, CT , USA
- Kimberly H. Allison, Pathology Department, Stanford University Medical Centre, Stanford, USA
- Koen K. van de Vijver, Department of Pathology, University Hospital Ghent, Belgium
- Konstanty (Popi) Korski, Data Science Imaging, Product Development – Personalized Healthcare, F.Hoffmann-La Roche Ltd., Basel, Switzerland
- Kosuke Kawaguchi, Department of Breast Surgery, Kyoto University, Kyoto, Japan.
- Kristin Galas – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Lajos Pusztai, Yale Cancer Center Genetics, Genomics and Epigenetics Program, Yale School of Medicine, New Haven, CT , USA
- Larissa Mendes, Oncology Department, Cancer Institute, University College London, London, United Kingdom
- Laura Comerma, Pathology Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain; GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain
- Laura Yee, National Cancer Institute, Maryland, USA
- Laurence Buisseret, Molecular Immunology Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Lax Sigurd, Department of Pathology, Hospital Graz II, Academic Teaching Hospital of the Medical University Graz, Austria
- Lee Cooper, Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
- Leming Shi, Center for Pharmacogenomics and Fudan-Zhangjiang, Center for Clinical Genomics School of Life Sciences and Shanghai Cancer Center, Fudan University, China
- Leonie Voorwerk, Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Leslie Cerpa – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Leslie Gilham, Consumer Advisory Panel, Breast Cancer Trials, Australia
- Lingyu Li, School of Control Science and Engineering, Shandong University, China
- Lisa McShane, Cancer Therapy Evaluation Program, National Cancer Institute, Maryland, USA
- Liudmila Beziaeva – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Loes Kooreman, Department of pathology, Maastricht University Medical Centre, Maastricht, The Netherlands
- LorenzoGianni -To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Lounis Khaled – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- LubomirBodnar – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Luc Dirix, Medical Oncology, GZA, Antwerp, Belgium
- Luciana Fujimoto, Pathology and Legal Medicine, Amazon Federal University, Brasil
- Luciana Molinero, Oncology Biomarker Development, Genentech-Roche
- Luis Claudio, Amendola Brazilian Socity of Oncology, Brazil
- Luisa Paola, Molteni – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Luz Sua, Department of Pathology, Fundación Valle del Lili, Cali, Colombia
- Valeria Estrada, Biorepository and Tissue Technology Shared Resources, University of California San Diego, USA
- Maartje van Seijen, Department of molecular pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands
- Magali Lacroix-Triki, Department of Pathology, Gustave Roussy, Villejuif, France
- Maggie Cheang, Institute of Cancer Research Clinical Trials and Statistics Unit, The Institute of Cancer Research, Surrey, United Kingdom
- Mahasti Saghatchian, Pathology, Institute Gustave Roussy, France
- Maise al Bakir, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, University College London, London, United Kingdom
- Makhlouf Ait Mouloud, Faculté de Médecine, Universite Mouloud MAMMERI, Algeria
- Mako Nogami – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Manish Manu Subramaniam, Anatomic Pathology, Q2 Lab Solutions, United Kingdom
- Manu Sebastian, Departments of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- Maria Cebollero, Pathology Department. Hospital General Universitario Gregorio Marañón. Madrid, Spain.
- Marcelo Balancin, Department of Pathology, Faculty of Medicine, University of São Paulo; São Paulo, Brazil
- Marcelo Souto Maior, Pathology, Federal University of Pernambuco, Brazil
- Maria Alice Franzoi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Maria Pia Foschini – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Maria Teresa Ramieri – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Maria Vittoria Dieci – Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy
- Marie-Christine Mathieu – Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France
- Mariia Urezkova- To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Marilyn Bui – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Marjan Hertoghs, Pathology department of ZNA and GZA hospitals in Antwerp, Belgium
- Mark Brown, Pathology, Q2 Solutions, United Kingdom
- Mark O’Loughlin- To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Mark Robson, Memorial Sloan Kettering Cancer Center, NY, US
- Mark Webber – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Mark van de Vijver, Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands
- Markus Herrmann – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org USA
- Marleen Kok, Divisions of Medical Oncology, Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Marlon C. Rebelatto, Translational Sciences, MedImmune, Gaithersberg, USA
- Martine Piccart, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium
- Martino Bosco, Pathology, ASLCN2, Italy
- Mary Schneck, Histogenex
- Masahiro Takada, Kyoto University, Department of Breast Surgery, Kyoto, Japan.
- Masakazu Toi, Department of Breast Surgery, Kyoto University, Kyoto, Japan.
- Masoumeh, Gharib, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- Matt Leavitt – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Matthew G. Hanna, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Matthew P. Goetz, Department of Oncology, Mayo Clinic, Rochester, USA
- Matthias Preusser, Department of Medicine, Clinical Division of Oncology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna, Austria
- Mehrnoush Khojasteh, Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA, USA
- Melinda E. Sanders, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Centre, Nashville, USA
- Melisa Vazquez – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Meredith M. Regan, Division of Biostatistics, Dana-Farber Cancer Institute, Boston, USA; Harvard Medical School, Boston, USA
- Michael Firer, Adelson School of Medicine, Ariel University, Israel
- Michael Barnes,Digital Pathology, Personalized Healthcare Group in Product Development, Genentech, USA
- Michael Christie, Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville, Australia
- Michael DiMaio, Pathology, DPMG, USA
- Michael Misialek , Vernon Cancer Center, Newton-Wellesley Hospital, Newton, USA
- Michail Sofopoulos, Department of Surgical Pathology, “Saint Savvas” Regional Anticancer Hospital, Athens Greece
- Michail Ignatiadis, Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Michiel de Maaker, Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Mieke Van Bockstal, Department of Pathology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
- MiglenaKomforti – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Miluska Castillo, Department of Research, Instituto Nacional de Enfermedades Neoplasicas, Lima 15038, Peru
- Minetta Liu, Mayo Clinic, Rochester, Minnesota Joint Appointment, Department of laboratory Medicine and Pathology, Research Chair, Division of Medical Oncology, USA
- Mitsuaki Ishida, Department of Pathology and Laboratory Medicine, Kansai Medical University, Osaka, Japan
- Mohamed Zaakouk – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Mohamed Amgad, Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA
- Mohamed Amgad Tageldin, Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA
- Molly Klein, Department of Laboratory Medicine and Pathology, University of Minnesota, USA
- Monica Modesto Araujo e Porfirio, Department of Pathology, Argos – Fortaleza-CE, Brazil
- Montse Velasco, Department of Oncology, Hospital de Mataro, Bercelona, Spain
- Morven Hollick, School of Medicine, Medical Science and Nutrition, University of Aberdeen, Scotland
- Nadia Villena – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Nadia Harbeck, Breast Center, Dept. OB&GYN and CCC (LMU), University of Munich, Munich, Germany
- Nadine Tung, Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, USA
- Naila Bacha – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Najat Bouchmaa, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal, Morocco
- Nancy Samberg, Executive Director, Medical Affairs, Iovance Biotherapeutics, USA
- Navita Somaiah, Translational Breast Radiobiology, Institute of Cancer Research, Honorary Consultant Clinical Oncologist (Breast), The Royal Marsden, United Kingdom
- Nele Laudus, Biomedical Quality Assurance Research Unit, KU Leuven, Leuven, Belgium
- Nicolas Sirtaine, Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
- Nicole Bussola – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Nicole Burchardi, German Breast Group GmbH, Germany
- Nikitina Vlada, Pathology, Krasnoyarsk State MEDICAL UNIVERSITY, Russia
- Nils Ternes, Service de Biostatistique et d’Epidémiologie, Gustave Roussy, CESP, Université-Paris Sud, Université Paris-Saclay, Villejuif, France
- Nina Radosevic-Robin, Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, Clermont-Ferrand, France
- Nobuhiro Shibata, Breast Surgery, Kansai Medical University Hospital, Osaka, Japan
- NoriyukiSaito – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Norie Abe, Breast Surgery, Nakagami Hospital, Okinawa, Japan
- Nuh Hatipoglu – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Ogugua Ajemba, Anatomic Pathology, Q2 Solutions, USA
- Oleg Gluz, Johanniter GmbH – Evangelisches Krankenhaus Bethesda Mönchengladbach, West German Study Group, Mönchengladbach, Germany
- Oliver Grimm, Pathology and Tissue Analytics, Roche
- Oluwole Fadare, Division of Anatomic Pathology, University of California San Diego Health System, USA
- Ovidiu Preda, Surgical Pathology, San Cecilio Hospital, Granada, Spain
- Paola Landini – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org Argentina
- Paola Mercurio, Anatomic Pathology, ASST Bergamo Ovest, Italy
- Paola Migliora – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Paolo Nuciforo, Molecular Oncology Group, Vall d’Hebron Institute of Oncology, Barcelona, Spain
- Pascal Valerie – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Patricia Lopez, Pathology, Instituto Nacional de Cancerologia, Colombia
- Paul Jank, Department of Pathology, University of Marburg, Marburg, Germany
- Paula Gonzalez Ericsson, Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee , USA
- Paulo Figueiredo – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Paulo Luz, Medical Oncology, Centro Hospitalar Universitario do Algarve, Faro, Portugal
- Pawan Kirtani, Department of Histopathology, Manipal Hospitals Dwarka, New Delhi, India
- Peggy Adam, Jules Bordet Institute, Belgium
- Petar Jelinic, Merck & Co., Inc., Kenilworth, USA
- Peter Regitnig – Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria
- Peter Savas, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia
- Peter Vermeulen, Medical Oncology, GZA, Antwerp, Belgium
- Peter H. Watson, Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
- Philippe Aftimos – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org Belgium
- Pia Waldenback – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Pieter Westenend – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Polina Dimitrova, Department of Pathology, University Hospital, Bulgary
- Pooja Vaid – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Popi Siziopikou, Department of Pathology, Breast Pathology Section, Northwestern University, Chicago, USA
- PrayuthRojpornpradit – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Perna Guleria, Army Hospital Research and Referral, Delhi Cantt, New Delhi, India
- Priyanka Sharma – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Prudence A. Francis, Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
- Raffaele Miele, ASL Napoli 1 Centro, Ospedale Pellegrini, Italy
- Raj Mohan, Command Hospital, India
- Rajendra Singh, Icahn School of Medicine at Mt. Sinai, New York, NY, USA
- RamonaErber – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Rashi Gupta – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Rashida Soni, Pathology, Q2 lab solutions and Henry Mayo Newhall Hospital, USA
- Rashindrie Perera, University of Melbourne, Australia
- Ravi Mehrotra – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Rebecca Dent, Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
- Reena Merard, Anatomic Pathology, Q2 Lab Solutions, USA
- Reena Rahayu, Department of Pathology and Diagnostic Laboratory Services, UKM Medical Centre, Kuala Lumpur, Malaysia
- Reena Ramsaroop – Surgical Pathologist, North Shore Hospital, WDHB, Auckland, New Zealand
- Remi Picot – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org France
- Rena Feinman – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Renan Andrade Pereira, Blazar SAS, Paris, France
- Ricardo Preda, Anatomical Pathology, NSW Health, Australia
- Richard Huang, Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA
- Rick Baehner, Genomic Health
- Rin Yamaguchi, Department of Pathology & Laboratory Medicine, Kurume University Medical Center, Fukuoka, Japan.
- Robert Mutter, Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA
- robert wightman To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Robert Hills Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford, UK United Kingdom
- Robert H. Pierce Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, USA USA
- Roberto Leon-Ferre Department of Oncology, Mayo Clinic, Rochester, USA USA
- Rocco Cappellesso Pathological Anatomy, Padova University Hospital Italy
- Roland de Wind Department of Pathology, Institut Jules Bordet, Brussels, Belgium Belgium
- Ronald Luff, Anatomic Pathology for Clinical Trials, Quest Diagnostics, USA
- Rongshan Yu – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Rosalia Caballero, GEICAM, Spain
- Ruben Cuesta – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Ruohong Shui, Department of Pathology, Fudan University Cancer Center, China
- Sabine Declercq, Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium
- Sabine Linn, Netherlands Cancer Institute, The Netherlands
- Saed Sadeghi – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Sam Leung, University of British Columbia, Vancouver, British Columbia, Canada
- Sami Tabbarah, Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
- Samy Stefan, Teoran Pathology, SCJUPBT, Romania
- Sandra Sarancone – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Sandra Souza, Oncology Merck & Co, New Jersey, USA
- Sandra O’Toole, The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Australian Clinical Labs, Australia
- Sandra Swain, Georgetown University Medical Center, Washington DC, USA
- Sangeeta Desai, Pathology, Tata Memorial Centre, India
- Sara Bonetto, U.O. Anatomia Patologica, ASST Lariana-Ospedale “Sant’Anna di Como”, Italy
- Sarah Dudgeon, FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, USA
- Scooter Willis, Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, SD, USA
- Scott Ely, Translational Medicine, Bristol-Myers Squibb, Princeton, USA
- Sean Hall, The Gillies McIndoe Research Institute, Wellington, New Zealand
- Seher Yuksel – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Seong-Rim Kim, National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, USA
- Shahinaz Bedri, Anatomic Pathology, Boston, Massachusetts, USA
- Sheeba Irshad, Guy’s Hospital, London, UK; King’s College London, London, United Kingdom
- Shigehira Saji, Medical Oncology, Fukushima Medical University Hospital, Japan
- Shi-Wei Liu, Sichuan Cancer Hospital, Chengdu, China
- Shom Goel, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
- Shona Hendry, Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia
- Shyam Kalavar – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Sidar Bagbudar – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Simon Palfreeman – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Simonetta Bianchi, Dipartimento di Scienze della Salute (DSS), Firenze, Italy
- Sneha Sant, Division of Research, Peter MacCallum Cancer Centre, Melbourne, Australia
- Sofia Tenorio – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Soonmyung Paik, National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, Pennsylvania, USA
- Sophia Turner, Patient advocate
- Sophie Van den Broek – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Stephan Wienert, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Charitéplatz 1, 10117 Berlin, Germany
- Stephen Naber, Department of Pathology and Laboratory Medicine, Tufts Medical Center, Boston, USA
- Stephen B. Fox, Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia
- Stephen J. Luen, Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia
- Steve Liu, Pathology, Washington University at St. Louis, USA
- Stuart Schnitt, Department of Pathology, Brigham and Women’s Hospital, Boston, MA; Dana-Farber Cancer Institute, Boston, MA, USA
- Sumana Dey, NCI
- Sundry DurÇn – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Sunil R. Lakhani, The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia
- Susan Fineberg, Department of Pathology, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA
- Susan Park – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Takahiro Kogawa, Japanese Foundation for Cancer Research, Tokyo, Japan
- Takashi Sakatani, Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan
- Takeru Okamoto, Chugai Pharmaceutical Co., Ltd, Japan
- Takuya Moriya, Department of Pathology, Kawasaki Medical School, Okayama, Japan
- Talia Fuchs, NSW Health Pathology, Sydney, Australia
- Tatsuki Kataoka, Department of Diagnostic Pathology, Kyoto University, Kyoto, Japan.
- Tatsunori Shimoi , National Cancer Center Hospital, Tokyo, Japan
- Teresa Soler, Department of Pathology, University Hospital of Bellvitge, Oncobell, IDIBELL, L’Hospitalet del Llobregat, Barcelona 08908, Catalonia, Spain
- Tessa Steenbruggen, Medical Oncology, The Netherland Cancer Institute, The Netherlands
- Tetsuo Hamada, Department of Surgical Pathology, JR Kyushu Hospital, Kitakyushu, Fukuoka, Japan
- Thiago Apolinario, Department of Oncology, IMIP, Brazil
- Thomas Gevaert, Department of Development and Regeneration, Laboratory of Experimental Urology, KU Leuven, Leuven, Belgium
- Tim Mandelkow – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Timothy d’Alfons, Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- Timothy Onyuma, Kenyatta National Hospital in Nairobi, Kenya.
- Tina Gruosso, Translational Research, Forbius, Montreal, Canada
- Toby Ellis – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Tom John, Department of Medical Oncology, Austin Health, Heidelberg, Australia
- Tomohagu Sugie, Department of Surgery, Kansai Medical School, Hirakata, Japan
- Tomoharu Sugie, Breast Surgery, Kansai Medical University Hospital, Osaka, Japan.
- Tony Kwon – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Toru Mukohara, National Cancer Center Hospital, Tokyo, Japan
- Tricia Saurine, Anatomical pathology, Royal North Shore Hospital, Australia
- Tsuyoshi Okamoto, Kyowa Kirin Co., Ltd, Japan
- Uday, Kurkure, Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA, USA
- Umay Kiraz, Pathology, Stavanger university hospital
- Valdivieso, Almeida – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Valentina Hoyos- To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Vasiliki Zolota – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Veerle Bossuyt – Department of Pathology, Massachusetts General Hospital, USA
- Veronica Bautista, Department of Pathology, Breast Cancer Center FUCAM, Mexico City, Mexico
- Vijay Sharma, Pathology, Liverpool Clinical Laboratories, Liverpool University Hospitals NHS Trust, United Kingdom
- Vincent Cockenpot, Department of Pathology, Léon Bérard Cancer Center, Lyon, France
- Vincent Engelen – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Vincent Laborie, Pathology, AMAPATH, France
- Vincente Peg, Cámaea Pathology Department, H.U. Vall d’Hebron, Barcelona, Spain
- Weida Tong, Division of Bioinformatics and Biostatistics, U.S. Food and Drug Administration, US
- Weijie Chen, Division of Imaging, Diagnostics, and Software Reliability (DIDSR), Office of Science and Engineering Laboratories (OSEL), Center for Devices and Radiological Health (CDRH), Rockville, USA
- Weijie Zhang – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Wentao Yang, Department of Pathology, Fudan University Cancer Center, China
- Wenxian Yang, Aginome Scientific Pte Ltd., Xiamen, China
- Wilhermo Torres, Pathology, Diagnose, Brazil
- William Gallagher – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- William Tran, Department of Radiation Oncology, University of Toronto, Toronto, Canada
- Yannick Waumans, Histogenex
- Yara Abdou – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Yazaki Shu, National Cancer Center Hospital, Tokyo, Japan
- Yihong Wang, Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center, Providence, USA
- Yinyin Yuan, Centre for Evolution and Cancer; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
- YongjunCha – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Yuan Li – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Yuchun Lin – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Yuichiro Kikawa, Breast Surgery, Kansai Medical University Hospital, Osaka, Japan.
- Yuji Kozuka, Department of Pathology, Mie University School of Medicine, Mie, Japan
- Yuri Kimura – To be completed, please contact roberto@salgado.be and/or jeannette.parrodi@petermac.org
- Zaheed Husain, Praava Health, Dhaka, Bangladesh
- Zheng Yuan, Histogenex, China
- Zsuzsanna Bago-Horvath, Department of Pathology, Medical University of Vienna, Vienna, Austria
- Zuzana Kos, Department of Pathology, BC Cancer Agency Vancouver Centre, Department of Pathology, Canada
*Update in progress. Please email roberto@salgado.be for any changes.